Take Solutions is on an aggressive mode to service the Indian pharma industry to meet the deadline of bar code implementation which will be effective from July 1, 2014.
The company has a range of products for the same in addition to track & trace solutions which will help the consumers to quickly find out whether the medicine is genuine or not. It also offers a comprehensive solution in software and hardware too. These include life sciences and supply chain management solutions which are Intellectual Property (IP) embedded covering enterprise mobility, trading partner collaboration, and material tracking. Specific to the lifesciences domain, Take offers IP-based software and extensive knowledge-based solutions to enable efficient clinical, regulatory, safety and commercialization processes.
In addition to meeting the regulatory needs, the company is working with a few leading pharma companies in implementing bar-coding solutions starting from raw material receipt, warehousing, dispensing, manufacturing and shipping. The details of the same were not disclosed. Pharma companies will be able to trace all raw material inputs to a specific batch of finished goods along with all manufacturing process data of the batch.
“Our solution will facilitate automate data capture at the ‘Point of Action or Transaction’ using our GEMINI NxG Mobility Solution. We firmly believe that our clients can go towards electronic record keeping (eBMR) by implementing our solution,” Ram Yeleswarapu, president & CEO, TAKE Solutions told Pharmabiz in an email interaction.
India currently being a hub of generic drug development activity lends itself to various opportunities for use. It product PharmaReady is much appreciated by users for its ease-of-use and effectiveness apart from meeting global regulatory guidelines while ensuring compliance, he added.
“It is an age of transparency going by the plethora of data being captured. We are increasingly getting involved in providing drug safety systems and quality management systems for the manufacturers abroad. Further, we have also been assisting companies in providing compliance enabled solutions for their manufacturing processes,” he said.
Take has been at the forefront of the rapidly evolving life sciences space. The availability of mass volumes of disparate data and the evolution of ‘big data’ technologies handling the volume, velocity and variety aspects with ease, analytics will take centre-stage for the life sciences industry.
In addition, the company also has sound understanding of the global macro healthcare environment, which includes epidemiology, clinical research, and medical device development. Coupled with peripheral data streams, Take has the solutions to allow the next generation data scientists to lead the way in analytics. This will define the final frontier for affordable and effective healthcare on a global basis, he said.